FDA DrugClass IINotable

FDA Recall: Synjardy XR Tablets (empagliflozin and metformin hydrochloride extended-release tablets), 12.5/1000

Date: 2026-07-08
Brand: Boehringer Ingelheim Pharmaceuticals, Inc.
Category: Drug
FDA Class: Class II

Description

CGMP Deviations: An incorrect detergent was used and the required swab sampling was not performed on a production hopper that had previously been used for a different product.

Hazard

CGMP Deviations: An incorrect detergent was used and the required swab sampling was not performed on a production hopper that had previously been used for a different product.

Remedy

560 bottles

Related Recalls